Document:

exv10w6

 

EXHIBIT 10.6

Introductory Note

     CapitalSource Inc. has entered into indemnification agreements in the form
attached hereto with the following executive officers as of the respective
dates listed opposite the name of the officer:

	 	 	 	 	 
	Officer	 	Date of
Indemnification Agreement
	
	 	

	 	Bryan M. Corsini	 	 	
August 1, 2003
	 	Dean C. Graham	 	 	
August 1, 2003
	 	Joseph A. Kenary, Jr.	 	 	
August 1, 2003
	 	Michael C. Szwajkowski	 	 	
August 1, 2003
	 	Donald F. Cole	 	 	
August 1, 2003
	 	Thomas A. Fink	 	 	
August 1, 2003
	 	James A. Mozingo	 	 	
[August 1, 2003]
	 	Steven A. Museles	 	 	
August 1, 2003

     Copies of the above agreements will be provided to the SEC upon request.

 

 

INDEMNIFICATION AGREEMENT

     THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made and entered into
as of August 1, 2003, by and between CapitalSource Inc., a Delaware corporation
(the “Company”), and the undersigned (the “Indemnitee”).

     WHEREAS, the Company has invited Indemnitee to serve as an executive
officer of the Company.

     WHEREAS, in order to induce Indemnitee to serve as an executive officer of
the Company, the Company wishes to grant and secure to Indemnitee as permitted
by 8 Del. C. § 145(f) indemnification and advancement rights to the fullest
extent permitted by Delaware law as the same exists or may hereafter be
revised, whether or not expressly provided for in the Company’s Amended and
Restated Bylaws or other provisions of the General Corporation Law of the State
of Delaware (the “DGCL”).

     NOW,
THEREFORE, in consideration of the Indemnitee’s agreement to serve as
an executive officer of the Company, and other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Company
agrees as follows:

     Section 1. Indemnification and Advancement Expenses.

          (a) If the Indemnitee is made a party or is threatened to be made a party
to or is otherwise involved, whether or not a party thereto, in any possible,
threatened, pending or completed action, suit, demand, arbitration, or
proceeding, whether civil, criminal, administrative or investigative
(hereinafter a “Proceeding”) or otherwise incurs, suffers, sustains or becomes
subject to any expense, liability, damage, costs, obligations, penalties,
claims or losses (including, without limitation, attorneys’ fees and expenses,
judgments, fines, Employee Retirement and Income Security Act excise taxes or
penalties and amounts paid or to be paid in settlement) (collectively,
“Losses”), arising out of, relating to, based upon, in connection with or due
to the fact that the Indemnitee is or was serving as an executive officer
(including, without limitation, as a member of any committee of the Board of
Directors) of the Company, any predecessor of the Company or any subsidiary of
the Company, or is or was serving at the request of the Company as a director
or officer of another corporation, partnership, joint venture, trust, or other
enterprise, including service with respect to an employee benefit plan, the
Indemnitee shall be indemnified and held harmless by the Company to the fullest
extent permitted by Delaware law against all Losses incurred, suffered or
sustained by the Indemnitee or to which the Indemnitee became subject in
connection with such service, except with respect to indemnification for
liability arising from a Proceeding initiated by the Indemnitee against the
Company (other than as described in Section 2) and unauthorized by the Board,
and such indemnification shall continue as to the

 

 

Indemnitee after the Indemnitee has ceased to serve as an executive officer of
the Company or in such other position as set forth above, and shall inure to
the benefit of the Indemnitee’s heirs, executors, administrators, conservators
and guardians.

          (b) The rights conferred upon the Indemnitee by this Agreement shall
include the right to be paid or reimbursed by the Company for any Losses from
time to time incurred, suffered or sustained by the Indemnitee or to which the
Indemnitee became subject in connection with such service, including, without
limitation, the expenses incurred in defending or otherwise being involved in
any such Proceeding or other action in advance of its final disposition
(hereinafter an “Advancement of Expenses”); provided, however, that if and only
if the DGCL so requires, such Advancement of Expense shall be made only upon
delivery to the Company of an undertaking (hereinafter an “Undertaking”), by or
on behalf of the Indemnitee, to repay all amounts so advanced if it shall
ultimately be determined by a final judicial decision from which there is no
further right to appeal (hereinafter a “Final Adjudication”), that the
Indemnitee is not entitled to be indemnified for such Losses under the DGCL.

     Section 2. Right of Indemnitee to Enforce Indemnification and Advancement
Obligations. If a claim under either (a) Section 1(a) of this Agreement with
respect to any right to indemnification is not paid in full by the Company
within sixty (60) days after a written claim for indemnification has been
received by the Company, or (b) Section 1(b) of this Agreement with respect to
any right to the Advancement of Expenses is not paid in full by the Company
within twenty (20) days after a written claim for Advancement of Expenses is
received by the Company, then the Indemnitee shall be entitled at any time
thereafter to bring suit against the Company to recover the unpaid amount of
any such claim. If successful in whole or in part in any such suit, the
Indemnitee shall be entitled additionally to be paid, and to seek as an award
in connection with any such suit, the cost and expenses (including attorneys’
fees) incurred by Indemnitee in prosecuting such suit. Neither the failure of
the Company (including its Board of Directors, independent legal counsel, or
its stockholders) to have made a determination prior to the commencement of
such suit that indemnification of the Indemnitee is proper in the circumstances
because the Indemnitee has met any applicable standard of conduct set forth in
Delaware Law, nor an actual determination by the Company (including its Board
of Directors, independent legal counsel, or its stockholders) that the
Indemnitee has not met any such applicable standard of conduct, shall be a
defense to the suit or create a presumption for purposes thereof that the
Indemnitee has not met any applicable standard of conduct.

     In any suit brought by the Indemnitee seeking to enforce a right to
indemnification or to an Advancement of Expenses under this Agreement, the
burden shall be on the Company to prove that the Indemnitee is not entitled to
be indemnified or to such Advancement of Expenses under this Agreement.

2

 

     Section 3. Rights Not Exclusive. The rights provided hereunder shall not
be deemed exclusive of any other right to which the Indemnitee may be entitled
or hereafter may acquire under any statute, provision of the Company’s Amended
and Restated Certificate of Incorporation or Amended and Restated Bylaws,
agreement, vote of stockholders or disinterested directors or otherwise, both
as to action in the Indemnitee’s official capacity and as to action in another
capacity while holding such office, and shall continue as to the Indemnitee
after the Indemnitee has ceased to be a director, officer, employee or agent of
the Company or as otherwise set forth in this Agreement and shall inure to the
benefit of the Indemnitee’s heirs, executors, administrators, conservators and
guardians.

     Section 4. D&O Insurance.

          (a) The Company hereby represents and warrants that Exhibit A contains a
complete and accurate description of the policies of directors’ and officers’
liability insurance purchased by the Company and that such policies are in full
force and effect.

          (b) The Company hereby covenants and agrees that, so long as Indemnitee
shall continue to serve as an executive officer of the Company, any predecessor
of the Company or any subsidiary of the Company, or is or was serving at the
request of the Company as a director or officer of another corporation,
partnership, joint venture, trust, or other enterprise, including service with
respect to an employee benefit plan, and thereafter so long as Indemnitee shall
be subject to any possible, threatened, pending or completed Proceeding arising
out of, relating to, based upon, in connection with or due to the fact that
Indemnitee was an executive officer of the Company, any predecessor of the
Company or any subsidiary of the Company, or is or was serving at the request
of the Company as a director or officer of another corporation, partnership,
joint venture, trust, or other enterprise, including service with respect to an
employee benefit plan, the Company shall maintain in full force and effect the
directors’ and officers’ liability insurance issued by the insurer(s), and
having the policy number(s), amount(s) and deductible(s) set forth on Exhibit A
hereto and any replacement or substitute policies issued by one or more
reputable insurers providing in all respects coverage at least comparable to
and in the same amount as that provided under the policy or policies identified
on Exhibit A (“D&O Insurance”).

          (c) In all policies of D&O Insurance, Indemnitee shall be named as an
insured in such a manner as to provide Indemnitee the same rights and benefits,
subject to the same limitations, as are accorded to the Company’s directors or
officers most favorably insured by such policy. The Company shall notify
Indemnitee in writing when this has occurred.

3

 

     Section 5. Settlement. The Company shall not settle any Proceeding in any
manner which would impose any fine or any obligation on the Indemnitee without
the Indemnitee’s prior written consent. The Indemnitee shall not unreasonably
withhold his consent to any proposed settlement.

     Section 6. Severability. In the event that any provision of this Agreement
is determined by a court to require the Company to do or to fail to do an act
which is in violation of applicable law, such provision shall be limited or
modified in its application to the minimum extent necessary to avoid a
violation of law, and, as so limited or modified, such provision and the
balance of this Agreement shall be enforceable in accordance with their terms.

     Section 7. Choice of Law. This Agreement shall be governed by and
construed and enforced in accordance with the internal laws of the State of
Delaware.

     Section 8. Successor and Assigns. This Agreement shall be (i) binding upon
all successors and assigns of the Company (including any transferee of all or
substantially all of its assets and successor by merger or otherwise by
operation of law) and (ii) shall be binding on and inure to the benefit of the
heirs, executors, administrators, conservators and guardians of Indemnitee.

     Section 9. Amendment. No amendment, modification, termination or
cancellation of this Agreement shall be effective unless made in a writing
signed by each of the parties hereto.

     Section 10. Waiver of Jury Trial. The Company and the Indemnitee hereby
waive any rights either may have to trial by jury in respect of any litigation
arising out of, relating to, based upon or in connection with this Agreement.

     Section 11. Limitation of Liability. The Indemnitee shall not be
personally liable to the Corporation or its stockholders for monetary damages
for breach of fiduciary duty as a director; provided, however, that the
foregoing shall not eliminate or limit the liability of the Indemnitee (i) for
any breach of the Indemnitee’s duty of loyalty to the Corporation or its
stockholders; (ii) for acts or omissions not in good faith or which involve
intentional misconduct or a knowing violation of the law; (iii) under Section
174 of the General Corporation Law of the State of Delaware; or (iv) for any
transaction from which the Indemnitee derived an improper personal benefit. If
the General Corporation Law of the State of Delaware shall be amended to permit
further elimination or limitation of the personal liability of directors, then
the liability of the Indemnitee shall, automatically, without any further
action, be eliminated or limited to the fullest extent permitted by the General
Corporation Law of the State of Delaware as so amended.

4

 

          IN WITNESS WHEREOF, the Company and the Indemnitee have executed this
Indemnification Agreement in duplicate as of the day and year first set forth
above.

	 	 	 	 	 
	 	 	 	 	CAPITALSOURCE INC.

	 	 	
By:
	 	

Name:

	 	 	 	 	Title:

	 	 	 	 	INDEMNITEE

	 	 	 	 	 
	 	 	 	 	

	 	 	 	 	Name:

5exv10w1

 

Exhibit 10.1

First Amendment to Asset Purchase Agreement

This First Amendment (the “Amendment”) to the Asset Purchase Agreement
dated December 15, 2000 by and among United Therapeutics Corporation, UP
Subsidiary Corporation and Cooke Pharma, Inc. (now Cooke PH, Inc.; and
referred to herein as “Cooke”) (the “Agreement”) is made and entered into
this    day of October 2003. United Therapeutics Corporation, UP
Subsidiary Corporation (now Unither Pharma, Inc.) and Cooke are
collectively referred to in this Amendment as the “parties”.

RECITALS

     WHEREAS, the Agreement was entered into by the parties on December 15,
2000; and

     WHEREAS, the parties desire to amend certain terms and provisions of the
Agreement.

          NOW, THEREFORE, in consideration of the foregoing and the mutual covenants
herein contained, and for other good and valuable consideration, the receipt
and sufficiency of which is hereby acknowledged, the parties agree that the
terms of the Agreement are amended as follows:

I.

The capitalized terms in this Amendment shall have the same definitions
ascribed to them in the Agreement to the extent that such capitalized terms
are defined therein and not defined in this Amendment

II.

The parties intend that no royalty payments shall be made to Cooke by UTC
and UP Subsidiary Corporation as a result of the Agreement. Accordingly,
(i) Article 2 of the Agreement is hereby deleted in its entirety and of no
further force and effect, (ii) all references in the Agreement to Article 2
and provisions thereof are hereby deleted in their entirety and of no
further force and effect, and (iii) as of the date of this Amendment and
hereafter, UTC and UP Sub shall not be required to make any payments of any
kind or nature to Cooke arising under Article 2 of the Agreement,
regardless of when such payment obligations may have arisen.

III.

The parties intend that the Escrow Securities currently held by the Escrow
Agent in accordance with the Escrow Agreement – 14,732 shares – shall be
promptly released by the Escrow Agent for the benefit of Cooke. The Escrow
Securities shall be released to UTC, and UTC shall take all steps necessary
to have the Escrow Securities (once released from escrow) reissued to Cooke
(or its designees, as indicated in writing by Cooke) by UTC’s transfer
agent (the “Reissue”). Accordingly, (i) the parties shall execute the
Joint Order Instruction attached at Exhibit 1 to this Amendment and UTC
shall cooperate with the Escrow Agent and its transfer agent to effect the
Reissue, (ii) upon Reissue, the Escrow Agreement shall be terminated by
agreement of the parties and shall be of no further force or effect, (iii)
all references in the Agreement to the Escrow Agreement and provisions
thereof shall be deleted in their entirety and of no further force and
effect, and (iv) as of the date of this Amendment and hereafter, Cooke
shall not be responsible for (A) the payment of any Designated Claim Losses
of UTC or UP Sub or (B) any Losses of UTC or UP Sub described in Section
8.1(a)(iii) of the Agreement (losses arising out of or in connection with
enforcement actions against infringers of Cooke Proprietary Rights), in
each case of any kind or nature arising under the Agreement, regardless of
when such payment obligations may have arisen.

IV.

The parties acknowledge that the 14,732 Escrow Shares to be re-issued to
Cooke in accordance with Section III above will not have been registered
under the Securities Act or the securities laws of any state and therefore
shall bear that restrictive legend described in Section 1.4(c) of the
Agreement, and that UTC shall have no obligation to register such

 

 

shares following the date of this Agreement. In connection with such
agreement, (i) the Registration Rights Agreement is hereby terminated in
its entirety and shall be of no further force or effect (subject to the
proviso at the end of this sentence), and (ii) all references in the
Agreement to the Registration Rights Agreement and provisions thereof shall
be deleted in their entirety and of no further force and effect; provided,
however, that, notwithstanding the termination of the Registration Rights
Agreement described herein, UTC hereby agrees to use reasonable efforts to
keep the Registration Statement on Form S-3 (Registration No. 333-99079)
originally filed with the SEC on August 30, 2002 (as subsequently amended
on October 17 and October 29, 2002, the “Registration Statement”),
effective pursuant to Rule 415 at all times until December 31, 2003
(including without limitation preparing and filing with the SEC such
post-effective amendments and supplements to the Registration Statement and
the prospectus used in connection with the Registration Statement as may be
necessary to keep each Registration Statement effective at all times
during the Registration Period and, during such period, complying with the
provisions of the 1933 Act with respect to the disposition of all
Registrable Securities covered by the Registration Statement).

V.

Except as expressly set forth in this Amendment, all terms and conditions
of the Agreement remain in full force and effect, and all terms and
conditions of the Agreement are incorporated herein as though set forth at
length. This Amendment modifies the Agreement. In the event of any
conflict or discrepancy between the Agreement and/or any other previous
documents between the parties and the provisions of this Amendment, then
the provisions of this Amendment shall control. Except as modified herein,
the Agreement shall remain in full force and effect.

     IN WITNESS WHEREOF, the parties have executed this Amendment by their
authorized officers to be effective as of the date first set forth above.

Cooke PH, Inc

(formerly Cooke Pharma, Inc.)

 
 

/s/ Joel Uchenick     /s/ John Cooke   Date: October 6, 2003

By: Joel Uchenick         John Cooke

Its: CFO                         Director

 
 

UNITED THERAPEUTICS CORPORATION

 
 

/s/ Paul Mahon                                  Date: October 7, 2003

Paul Mahon

General Counsel and Corporate Secretary

 
 

UNITHER PHARMA, INC.

(formerly UP Subsidiary Corporation)

 
 

/s/ Paul Mahon                               Date: October 7, 2003

Paul Mahon

General Counsel and Corporate Secretary

2

 

Exhibit 1

Joint Order Instruction

     In accordance with the terms of United Therapeutics’ acquisition of
substantially all the assets of Cooke Pharma, Inc. (now Cooke PH, Inc.) and
the agreement with Chicago Title & Trust as Escrow Agent, Chicago Title &
Trust is holding 14,732 shares of United Therapeutics common stock in the
Cooke Acquisition Escrow.

     The Parties to the Escrow Agreement hereby jointly instruct Chicago
Title and Trust to terminate the escrow and deliver the existing certificate
currently held in the Cooke Acquisition Escrow to United Therapeutics
Corporation (attention: Paul Mahon, General Counsel and Corporate Secretary
of United Therapeutics Corporation). Such shares are delivered to United
Therapeutics Corporation for the benefit of Cooke PH, Inc. United
Therapeutics will then promptly reissue (through its transfer agent) and
deliver to Cooke PH, Inc. a new certificate representing 14,732 shares of
United Therapeutics common stock in the name of Cooke PH, Inc. or its
designees, as contemplated by the First Amendment to the Asset Purchase
Agreement dated as of the date hereof.

ACCEPTED AND AGREED TO:

Cooke PH, Inc

(formerly Cooke Pharma, Inc.)

 
 

/s/ Joel Uchenick       /s/ John Cooke   Date: October 6, 2003

By: Joel Uchenick         John Cooke

Its: CFO                         Director

 
 

UNITED THERAPEUTICS CORPORATION

 
 

/s/ Paul Mahon                                      Date: October 7, 2003

Paul Mahon

General Counsel and Corporate Secretary

 
 

UNITHER PHARMA, INC.

(formerly UP Subsidiary Corporation)

 
 

/s/ Paul Mahon                                     Date: October 7, 2003

Paul Mahon

General Counsel and Corporate Secretary

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00057-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00057-of-00352.parquet"}]]